Trichokaurin is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity against leukemia and hepatocellular carcinoma cells by inducing apoptosis and blocking cell cycle progression. Research also suggests it may modulate signaling pathways involved in inflammation and cell survival, such as NF-κB and MAPK pathways. Due to these biological effects, Trichokaurin is used in preclinical research to explore new therapeutic strategies for cancer and inflammatory diseases. Its application remains largely experimental, confined to laboratory studies and in vitro models.